Catarina Nilsson
About
Catarina Nilsson is a scholar working on Surgery, Biochemistry and Cardiology and Cardiovascular Medicine.
According to data from OpenAlex, Catarina Nilsson has authored 25 papers receiving a total of 455 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 6 papers in Biochemistry and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Catarina Nilsson's work include Lipoproteins and Cardiovascular Health (9 papers), Fatty Acid Research and Health (4 papers) and Gastroesophageal reflux and treatments (3 papers). Catarina Nilsson is often cited by papers focused on Lipoproteins and Cardiovascular Health (9 papers), Fatty Acid Research and Health (4 papers) and Gastroesophageal reflux and treatments (3 papers). Catarina Nilsson collaborates with scholars based in Sweden, United States and United Kingdom. Catarina Nilsson's co-authors include Jan W. Eriksson, Lars Löfgren, Hans Denison, Mikael Knutsson, Christian von Corswant, Hans Lennernäs, Lennart Lindfors, Sara Carlert, Bertil Abrahamsson and Gunilla Hanisch and has published in prestigious journals such as Circulation, Gastroenterology and Journal of the American College of Cardiology.
In The Last Decade
Catarina Nilsson
25 papers receiving 441 citations
Peers
Catarina Nilsson
Quan Zhou China
Kazuko Sagawa United States
Richard Czerniak United States
Sandra K. Kirkman United Kingdom
S.G. Barnwell United Kingdom
Goran Miljuš Serbia
Yow‐Shieng Uang Taiwan
Rebecca L. Oberle United States
Carlos Rodríguez Ulloa Mexico
S. A. Qureshi Canada
Citations per year, relative to Catarina Nilsson Catarina Nilsson (= 1×)
peers
Quan Zhou
Countries citing papers authored by Catarina Nilsson
Since
Specialization
Citations
This map shows the geographic impact of Catarina Nilsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catarina Nilsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catarina Nilsson more than expected).
Fields of papers citing papers by Catarina Nilsson
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Catarina Nilsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catarina Nilsson. The network helps show where Catarina Nilsson may publish in the future.
Co-authorship network of co-authors of Catarina Nilsson
This figure shows the co-authorship network connecting the top 25 collaborators of Catarina Nilsson. A scholar is included among the top collaborators of Catarina Nilsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catarina Nilsson. Catarina Nilsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Rekić, Dinko, Angelica Quartino, Björn Carlsson, et al.. (2024). Population pharmacokinetics of a novel PCSK9 antisense oligonucleotide. British Journal of Clinical Pharmacology. 90(6). 1503–1513.
2.
Koren, Michael J., Alexis Hofherr, Jennifer Schumi, et al.. (2022). ETESIAN: A PHASE 2B STUDY OF THE EFFICACY, SAFETY AND TOLERABILITY OF AZD8233, A PCSK9-TARGETED ANTISENSE OLIGONUCLEOTIDE, IN PATIENTS WITH DYSLIPIDEMIA. Journal of the American College of Cardiology. 79(9). 1475–1475.
3.
Nilsson, Catarina, Björn Carlsson, Alexis Hofherr, et al.. (2022). A case‐study of model‐informed drug development of a novel PCSK9 anti sense oligonucleotide. Part 1: First time in man to phase II. CPT Pharmacometrics & Systems Pharmacology. 11(12). 1569–1577.
4.
Dunbar, Richard L., Daniel Gaudet, Michael H. Davidson, et al.. (2020). Omega-3 fatty acid exposure with a low-fat diet in patients with past hypertriglyceridemia-induced acute pancreatitis; an exploratory, randomized, open-label crossover study. Lipids in Health and Disease. 19(1). 117–117.
5.
Sokolov, Victor, Gabriel Helmlinger, Catarina Nilsson, et al.. (2019). Comparative quantitative systems pharmacology modeling of anti-PCSK9 therapeutic modalities in hypercholesterolemia. Journal of Lipid Research. 60(9). 1610–1621.
6.
Gutierrez, Pablo Morentin, et al.. (2019). Evolving data analysis of an Oral Lipid Tolerance Test toward the standard for the Oral Glucose Tolerance Test: Cross species modeling effects of AZD 7687 on plasma triacylglycerol. Pharmacology Research & Perspectives. 7(2). e00465–e00465.
7.
Lindkvist, Björn, Catarina Nilsson, Mats Kvarnström, & Jan Oscarsson. (2018). Importance of pancreatic exocrine dysfunction in patients with type 2 diabetes: A randomized crossover study. Pancreatology. 18(5). 550–558.
8.
Offman, Elliot, Michael H. Davidson, & Catarina Nilsson. (2017). No Effect of Omega-3 Carboxylic Acids on Pharmacokinetics/Pharmacodynamics of Warfarin or on Platelet Function When Co-administered with Acetylsalicylic Acid: Results of Two Phase I Studies in Healthy Volunteers. American Journal of Cardiovascular Drugs. 17(3). 251–260.
9.
Offman, Elliot, Michael H. Davidson, & Catarina Nilsson. (2017). Assessment of pharmacokinetic interaction between omega-3 carboxylic acids and the statins rosuvastatin and simvastatin: Results of 2 phase I studies in healthy volunteers. Journal of clinical lipidology. 11(3). 739–748.
10.
Offman, Elliot, et al.. (2017). Systemic Bioavailability and Dose Proportionality of Omega-3 Administered in Free Fatty Acid Form Compared With Ethyl Ester Form: Results of a Phase 1 Study in Healthy Volunteers. European Journal of Drug Metabolism and Pharmacokinetics. 42(5). 815–825.
11.
Shimada, Hitoshi, et al.. (2017). Effects of Food on the Pharmacokinetics of Omega-3-Carboxylic Acids in Healthy Japanese Male Subjects: A Phase I, Randomized, Open-label, Three-period, Crossover Trial. Journal of Atherosclerosis and Thrombosis. 24(9). 980–987.
12.
Oscarsson, Jan, Catarina Nilsson, Mats Kvarnström, & Björn Lindkvist. (2017). Type 2 Diabetes and Pancreatic Exocrine Function: Associations Between Fecal Elastase-1 Levels and Gastrointestinal Symptoms, Plasma Nutritional Markers, and Uptake of Free Versus Esterified Omega-3 Fatty Acids in a Randomized, Open-Label, Crossover Study. Gastroenterology. 152(5). S899–S899.
13.
Nilsson, Catarina, et al.. (2017). Safety, Tolerability, and Pharmacokinetics of Single and Multiple Oral Doses of an Omega‐3‐Carboxylic Acid Formulation in Healthy Male Japanese Subjects: A Phase 1 Single‐Blind, Randomized, Placebo‐Controlled Trial. Clinical Pharmacology in Drug Development. 7(2). 177–187.
14.
Gutierrez, Pablo Morentin, John G. Swales, Jan W. Eriksson, et al.. (2015). Continuous inhibition of 11β‐hydroxysteroid dehydrogenase type I in adipose tissue leads to tachyphylaxis in humans and rats but not in mice. British Journal of Pharmacology. 172(20). 4806–4816.
15.
Omari, Taher, et al.. (2015). Pharmacokinetics and Acid‐suppressive Effects of Esomeprazole in Infants 1–24 Months Old With Symptoms of Gastroesophageal Reflux Disease. Journal of Pediatric Gastroenterology and Nutrition. 60(S1). S2–8.
16.
Denison, Hans, Catarina Nilsson, Lars Löfgren, et al.. (2013). Diacylglycerol acyltransferase 1 inhibition with AZD7687 alters lipid handling and hormone secretion in the gut with intolerable side effects: a randomized clinical trial. Diabetes Obesity and Metabolism. 16(4). 334–343.
17.
Denison, Hans, Catarina Nilsson, Lars Löfgren, et al.. (2012). Proof of mechanism for the DGAT1 inhibitor AZD7687 : results from a first‐time‐in‐human single‐dose study. Diabetes Obesity and Metabolism. 15(2). 136–143.
18.
Carlert, Sara, Gunilla Hanisch, Christian von Corswant, et al.. (2010). Predicting Intestinal Precipitation—A Case Example for a Basic BCS Class II Drug. Pharmaceutical Research. 27(10). 2119–2130.
19.
Omari, Taher, et al.. (2007). Pharmacokinetics and Acid‐suppressive Effects of Esomeprazole in Infants 1–24 Months Old With Symptoms of Gastroesophageal Reflux Disease. Journal of Pediatric Gastroenterology and Nutrition. 45(5). 530–537.
20.
Sunesson, Anna-Lena, Catarina Nilsson, Richard W. Carlson, Göran Blomquist, & B. Andersson. (1997). Production of volatile metabolites from streptomyces albidoflavus cultivated on gypsum board and tryptone glucose extract agar-influence of temperature, oxygen and carbon dioxide levels. The Annals of Occupational Hygiene. 41(4). 393–413.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Quan Zhou Breakdown of academic impact, for papers by Kazuko Sagawa Breakdown of academic impact, for papers by Richard Czerniak Breakdown of academic impact, for papers by Sandra K. Kirkman Breakdown of academic impact, for papers by S.G. Barnwell Breakdown of academic impact, for papers by Goran Miljuš Breakdown of academic impact, for papers by Yow‐Shieng Uang Breakdown of academic impact, for papers by Rebecca L. Oberle Breakdown of academic impact, for papers by Carlos Rodríguez Ulloa Breakdown of academic impact, for papers by S. A. Qureshi